Deerland Probiotics and Enzymes has announced that it has received a GRAS (generally recognized as safe) no-objection letter for FDA for its Bacillus subtilis DE111 branded probiotic.
Photo © Shutterstock.com/AlexLMX
Deerland Probiotics and Enzymes (Kennesaw, GA) has announced that it has received a GRAS (generally recognized as safe) no-objection letter for FDA for its Bacillus subtilis DE111 branded probiotic. The letter was sent in response to a GRAS self-affirmation dossier submitted by Deerland and means that FDA does not question the basis of the GRAS self-affirmation, following a review of the scientific data.
“We are excited to receive the FDA’s no objection letter for DE111,” said Scott Ravech, CEO of Deerland, in a press release. “It highlights the extensive research, including the clinical trials that have been conducted by our team, and we are proud of this accomplishment.”
In addition to this, DE111 has received non-novel food status in both Canada and Australia, and has been approved as a natural health product ingredient by Health Canada.
Judge denies CRN’s motion for preliminary injunction but its lawsuit against NY state will proceed
April 23rd 2024The judge in CRN's lawsuit against NY state's law banning the sale of weight management and muscle building supplements to minors has denied its motion for a preliminary injunction, but determined that CRN has standing to sue on behalf of its members.
CRN NY State lawsuit update: Dispatch from SupplySide East 2024
April 18th 2024CRN's Steve Mister updates Nutritional Outlook about its ongoing litigation against NY State. The organization sued the state to prevent the enforcement of law that bans sale of weight management supplements to minors.